NY State Senate Bill 2009-S1197

Senate Bill S1197

2009-2010 Legislative Session

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 25, 2010	print number 1197a
Jan 25, 2010	amend and recommit to health
Jan 06, 2010	referred to health
Jan 27, 2009	referred to health

Bill Amendments

Original

A (Active)

2009-S1197 - Details

See Assembly Version of this Bill:: A3075
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-H & 630-c, Tax L; add §97-jjjj, St Fin L
Versions Introduced in Other Legislative Sessions:: 2011-2012: S569, A283
2013-2014: S1976, A558
2015-2016: A49
2017-2018: A1354
2019-2020: A4481

2009-S1197 - Summary

Provides a program to promote leukemia, lymphoma and myeloma research education and treatment and establishes the leukemia, lymphoma and myeloma research education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift an individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

2009-S1197 - Sponsor Memo

                                 BILL NUMBER:  S1197

 TITLE OF BILL :
An act to amend the public health law, the tax law and the state
finance law, in relation to providing for taxpayer gifts for leukemia,
lymphoma and myeloma research, education and treatment and
establishing the leukemia research, education and treatment fund


 PURPOSE :
The purpose of this bill is to provide easy access to help fund and
support Leukemia, Lymphoma, and Myeloma research, education and
treatment.

 SUMMARY OF PROVISIONS :
Section 1 - Amends the public health law by adding a new article
27-CCC.  The new article provides the Commissioner of Health with the
powers to:  develop programs concerning Leukemia, it Lymphoma, and
Myeloma, to accept and expend grants, awards and other funding, and to
enter into contracts necessary for program development and granting.

Section 2 - Amends the law by adding a new section 209-G. The new
section provides for the Commissioner of Taxation and Finance to
include a space on the corporate income tax return for contributions
to Leukemia, Lymphoma, and Myeloma research, education and treatment.

Section 3 - Amends part 2 of article 22 of the tax law by adding a new
section 630. The new section provides for the Commissioner of Taxation
and Finance to include a space on the individual income tax return for
contributions to Leukemia, Lymphoma, and Myeloma research, education
and treatment.

Section 4 - Amends the state finance law by adding a new section
97-ffff. The new section provides for the establishment of a special
fund, consisting of revenues received under section 209-G and 630 of
the tax law and any other money's appropriated, credited or
transferred, for Leukemia, Lymphoma and Myeloma research, education
and treatment. The custody of this fund will be held jointly by the
Commissioner of Taxation and Finance and the Comptroller. Further, the
new section provides that all monies in the fund to be used only for
Leukemia, Lymphoma and Myeloma research, education and treatment
programs approved by the Department of Health. Further, the new
section provides that the Comptroller must approve releases of money
that are certified by the Commissioner of Health and that all money in
the fund should be used prior to the end of the fiscal year.

 JUSTIFICATION :
Research and treatment efforts for many diseases, ,including
Alzheimer's and breast cancer, have benefited from additional funding
resulting from having a "check-off box" placed on the individual and
corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood
cancers originating in the bone marrow and correlate with each other
because of the unrestrained growth of the cells and the parallel
functions which they possess. Leukemia, although more common in adults
over the age of 64, is still the leading cause of death of children
under 15 yrs old, wit,h Acute Lymphocytic Leukemia (ALL) being the
most common form of Leukemia in children. Treatment advances for
Leukemia have proven to be prevalent in the survival rate over' the
years, with the survival rate increasing from 4% in 1960 to 85% in
1999. Lymphoma involves two particular forms including Non-Hodgkin,
which is the fifth most common cancer in the U.S.  and Hodgkin
Lymphoma, which mostly effects adolescents and young adults.  Myeloma
occurs mostly in people over 60 years old with males having a 50%
higher chance than females of being diagnosed. Each year an estimated
106,200 people in the united States are diagnosed with Leukemia,
Lymphoma, or Myeloma. At the present time, an estimated 670,950
Americans have blood cancers. Approximately 57,500 Americans will die
from these hematological malignancies this year. In New York State
alone, there are approximately 6,600 people diagnosed with a blood
cancer each year and 3,500 people will succumb to this disease.

 LEGISLATIVE HISTORY :
01/09/08 REFERRED TO HEALTH

 FISCAL IMPLICATIONS :
None.

 EFFECTIVE DATE :
This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2010.

2009-S1197 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1197

                       2009-2010 Regular Sessions

                            I N  S E N A T E

                            January 27, 2009
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma and myeloma research, education and treatment and establishing  the
  leukemia research, education and treatment fund

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The public health law is amended by adding  a  new  article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION  2747.  LEUKEMIA,  LYMPHOMA  AND MYELOMA RESEARCH, EDUCATION AND
               TREATMENT.
  S 2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT.   THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA AND MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION,  THE  COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1.  TO  PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS DESIGNED TO
REDUCE OR PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA,  LYMPHOMA  AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS  AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS AS
TO THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE  FUNDS
BY THE STATE FINANCE LAW; AND
  3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S 2. The tax law is amended by adding a new section 209-G to  read  as
follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01796-01-9

S. 1197                             2

  S  209-G.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY FIRST, TWO THOUSAND TEN, A TAXPAYER IN ANY TAXABLE YEAR MAY ELECT TO
CONTRIBUTE  TO  THE  SUPPORT  OF  THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION  AND  TREATMENT FUND. SUCH CONTRIBUTION SHALL BE IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED BY SUCH TAXPAYER. THE  COMMISSIONER  SHALL  INCLUDE  SPACE  ON  THE
CORPORATE  INCOME  TAX RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIB-
UTION.  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL   REVENUES
COLLECTED  PURSUANT  TO  THIS SECTION SHALL BE CREDITED TO THE LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-JJJJ  OF
THE STATE FINANCE LAW.
  S  3.  The tax law is amended by adding a new section 630-b to read as
follows:
  S 630-B. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
ARY FIRST, TWO THOUSAND TEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY ELECT
TO CONTRIBUTE TO THE LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH,  EDUCATION
AND  TREATMENT  FUND.  SUCH  CONTRIBUTION  SHALL  BE IN ANY WHOLE DOLLAR
AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH  INDI-
VIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME TAX
RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIBUTION.   NOTWITHSTANDING
ANY  OTHER  PROVISION  OF  LAW  ALL  REVENUES COLLECTED PURSUANT TO THIS
SECTION  SHALL  BE  CREDITED  TO  THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-JJJJ OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-jjjj
to read as follows:
  S  97-JJJJ.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-G AND SECTION SIX HUNDRED THIRTY-B OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH, PURSUANT TO SECTION TWO THOUSAND SEVEN HUNDRED FORTY-
SEVEN OF THE PUBLIC HEALTH  LAW,  ARE  APPROVED  BY  THE  DEPARTMENT  OF
HEALTH.    SUCH  GRANTS  MAY INCLUDE, AMONG OTHERS, GRANTS TO PUBLIC AND
PRIVATE HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER  ORGANIZA-
TIONS.
  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.

S. 1197                             3

  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2010.

2009-S1197A (ACTIVE) - Details

See Assembly Version of this Bill:: A3075
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-H & 630-c, Tax L; add §97-jjjj, St Fin L
Versions Introduced in Other Legislative Sessions:: 2011-2012: S569, A283
2013-2014: S1976, A558
2015-2016: A49
2017-2018: A1354
2019-2020: A4481

2009-S1197A (ACTIVE) - Summary

2009-S1197A (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S1197A

 TITLE OF BILL :
An act to amend the public health law, the tax law and the state
finance law, in relation to providing for taxpayer gifts for leukemia,
lymphoma and myeloma research, education and treatment and
establishing the leukemia research, education and treatment fund


 PURPOSE OR GENERAL IDEA OF BILL :
The purpose of this bill is to provide easy access to help fund and
support Leukemia. Lymphoma, and Myeloma research, education and
treatment.

 SUMMARY OF SPECIFIC PROVISIONS :
Section 1 - Amends the public health law by adding a new article
27-CCC. The new article provides the Commissioner of Health with the
powers to: develop programs concerning Leukemia, Lymphoma. and
Myeloma, to accept and expend grants. awards and other funding, and to
enter into contracts necessary for program development and granting.
Section 2 - Amends the law by adding a new section 209-H. The new
section provides for the Commissioner of Taxation and Finance to
include a space on the corporate income tax return for contributions
to Leukemia, Lymphoma, and Myeloma research, education and treatment.
Section 3 - Amends part 2 of article 22 of the tax law by adding new
section 630-c. The new section provides for the Commissioner of

Taxation and Finance to include a space on the individual income tax
return for contributions to Leukemia, Lymphoma, and Myeloma research,
education and treatment.
Section 4 - Amends the state finance law by adding a new section
97-jjjj. The new section provides for the establishment of a special
fund, consisting of revenues received under section 209-H and 630-c of
the tax law and any other moneys appropriated, credited or
transferred, for Leukemia, Lymphoma and Myeloma research, education
and treatment. The custody of this fund will be held jointly by the
Commissioner of Taxation and Finance and the Comptroller. Further, the
new section provides that all monies in the fund to be used only for
Leukemia, Lymphoma and Myeloma research, education and treatment
programs approved by the Department of Health. Additionally, the new
section provides that the Comptroller must approve releases of money
that are certified by the Commissioner of Health and that all money in
the fund should be used prior to the end of the fiscal year.

 JUSTIFICATION :
Research and treatment efforts for many diseases.  including
Alzheimer's and breast cancer. have benefited from additional funding
resulting from having a "check-off box" placed on the individual and
corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood
cancers originating in the bone marrow and correlate with each other
because of the unrestrained growth of the cells and the parallel
functions which they possess.  Leukemia, although more common in
adults over the age of 64, is still the leading cause of disease death
of children under 15 yrs old, with Acute Lymphocytic Leukemia (ALL)
being the most common form of Leukemia in children. Treatment advances
for Leukemia have proven to be prevalent in the survival rate over the
years, with the survival rate increasing from 4% in 1960 to 85% in
1999. Lymphoma involves two particular forms including Non-Hodgkin,
which is the fifth most common cancer in the U.S. and Hodgkin
Lymphoma, which mostly affects adolescents and young adults. Myeloma
occurs mostly in people over 60 yrs old with males having a 50% higher
chance than females of being diagnosed. Each year an estimated 106.200
people in the United States are diagnosed with Leukemia, Lymphoma, or
Myeloma. At the present time, an estimated 670,950 Americans have
blood cancers.  Approximately 57,500 Americans will die from these
hematological malignancies this year. In New York State alone, there

are approximately 6,600 people diagnosed with a blood cancer each year
and 3,500 people will succumb to this disease.

 PRIOR LEGISLATIVE HISTORY :
2009:  A.3075 Passed Assembly
2008:  A.1558-C Passed Assembly
2007:  A.1558-A Passed Assembly
2006:  A.3338-A Passed Assembly; S.2871-A Died in Senate Health
2005:  A.3338 Passed Assembly
2004:  A.9816 Passed Assembly; Died in Senate Health

 FISCAL IMPLICATIONS :
Minimal to the state.

 EFFECTIVE DATE :
This act shall apply to taxable years commencing on or after January
1, 2011.

2009-S1197A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1197--A

                       2009-2010 Regular Sessions

                            I N  S E N A T E

                            January 27, 2009
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health --  recommitted  to
  the  Committee  on  Health in accordance with Senate Rule 6, sec. 8 --
  committee discharged, bill amended, ordered reprinted as  amended  and
  recommitted to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
               TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS
TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND
  3. TO ENTER INTO CONTRACTS WITHIN THE AMOUNTS  AVAILABLE  THEREFOR  AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01796-03-0

S. 1197--A                          2

  S  2.  The tax law is amended by adding a new section 209-H to read as
follows:
  S  209-H.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY FIRST, TWO THOUSAND ELEVEN, A TAXPAYER IN ANY TAXABLE YEAR MAY ELECT
TO  CONTRIBUTE  TO  THE  SUPPORT  OF  THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-JJJJ OF
THE STATE FINANCE LAW.
  S 3. The tax law is amended by adding a new section 630-c to  read  as
follows:
  S  630-C.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND ELEVEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-JJJJ OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-jjjj
to read as follows:
  S  97-JJJJ.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-H AND SECTION SIX HUNDRED THIRTY-C OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH, PURSUANT TO SECTION TWO THOUSAND SEVEN HUNDRED FORTY-
SEVEN OF THE PUBLIC HEALTH  LAW,  ARE  APPROVED  BY  THE  DEPARTMENT  OF
HEALTH.    SUCH  GRANTS  MAY INCLUDE, AMONG OTHERS, GRANTS TO PUBLIC AND
PRIVATE HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER  ORGANIZA-
TIONS.

S. 1197--A                          3

  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.
  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2011.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.